U.S. P2Y12 Inhibitors Market Projected To Witness Substantial Growth, 2024-2031: AstraZeneca, Genentech, Lupin, Cipla
U.S. P2Y12 Inhibitors Market is estimated to have around US$ 215.7 Mn in 2024 and is expected to exhibit a CAGR of 3.8% during the forecast period (2024-2031). BURLINGAME, CA, UNITED STATES, September 27, 2024 /EINPresswire.com/ -- Latest Report …